Literature DB >> 6174077

In vitro utilization of mucin by Bacteroides fragilis.

A M Roberton, R A Stanley.   

Abstract

A method for isolating pig colon mucin in a soluble high-molecular-weight form, suitable for addition to bacterial growth media, is described. This preparation was utilized as a sole carbohydrate energy source by two strains of Bacteroides fragilis. The extent of degradation was compared with that of commercial pig gastric mucin by the same strains. Gas-liquid chromatographic analysis of the mucin carbohydrates and gel chromatography of the preparations were carried out before and after in vitro degradation. The mucin carbohydrates were utilized only to a very limited extent, colon mucin being more resistant to degradation than gastric mucin. Both mucins chromatographed at or near the excluded volume on Sepharose 4B, and only in the case of ATCC 25285 grown on gastric mucin was a significant degradation peak detected. If mucins are degraded in vivo by the sequential action of several bacteria, a pure culture in vitro might be expected to degrade mucins to a limited extent only. Techniques previously used to examine mucin utilization by pure cultures may have overlooked limited mucin degradation demonstrated by the methods used in this work.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174077      PMCID: PMC241826          DOI: 10.1128/aem.43.2.325-330.1982

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  18 in total

1.  Isolation and structural studies of sulfated glycoproteins of hog gastric mucosa.

Authors:  B L Slomiany; K Meyer
Journal:  J Biol Chem       Date:  1972-08-25       Impact factor: 5.157

2.  Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon.

Authors:  A A Salyers; J R Vercellotti; S E West; T D Wilkins
Journal:  Appl Environ Microbiol       Date:  1977-02       Impact factor: 4.792

3.  Chemical aspects of mucus. General considerations.

Authors:  J R Clamp
Journal:  Br Med Bull       Date:  1978-01       Impact factor: 4.291

4.  A gas-liquid chromatographic approach to the analysis of carbohydrates.

Authors:  J R Clamp
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

5.  Requirement of heme for growth of Bacteroides fragilis.

Authors:  J F Sperry; M D Appleman; T D Wilkins
Journal:  Appl Environ Microbiol       Date:  1977-10       Impact factor: 4.792

6.  Medium without rumen fluid for nonselective enumeration and isolation of rumen bacteria.

Authors:  D R Caldwell; M P Bryant
Journal:  Appl Microbiol       Date:  1966-09

7.  The faecal flora in ulcerative colitis.

Authors:  J A van der Wiel-Korstanje; K C Winkler
Journal:  J Med Microbiol       Date:  1975-11       Impact factor: 2.472

8.  Degradation of blood group antigens in human colon ecosystems. II. A gene interaction in man that affects the fecal population density of certain enteric bacteria.

Authors:  L C Hoskins; E T Boulding
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

9.  An assessment of methanolysis and other factors used in the analysis of carbohydrate-containing materials.

Authors:  R E Chambers; J R Clamp
Journal:  Biochem J       Date:  1971-12       Impact factor: 3.857

10.  Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon.

Authors:  A A Salyers; S E West; J R Vercellotti; T D Wilkins
Journal:  Appl Environ Microbiol       Date:  1977-11       Impact factor: 4.792

View more
  27 in total

1.  A novel mechanism for desulfation of mucin: identification and cloning of a mucin-desulfating glycosidase (sulfoglycosidase) from Prevotella strain RS2.

Authors:  Jung-hyun Rho; Damian P Wright; David L Christie; Keith Clinch; Richard H Furneaux; Anthony M Roberton
Journal:  J Bacteriol       Date:  2005-03       Impact factor: 3.490

2.  A Two-Component System Regulates Bacteroides fragilis Toxin to Maintain Intestinal Homeostasis and Prevent Lethal Disease.

Authors:  Aaron L Hecht; Benjamin W Casterline; Vivian M Choi; Juliane Bubeck Wardenburg
Journal:  Cell Host Microbe       Date:  2017-09-21       Impact factor: 21.023

3.  The human commensal Bacteroides fragilis binds intestinal mucin.

Authors:  Julie Y Huang; S Melanie Lee; Sarkis K Mazmanian
Journal:  Anaerobe       Date:  2011-06-02       Impact factor: 3.331

4.  Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.

Authors:  A R Colina; F Aumont; N Deslauriers; P Belhumeur; L de Repentigny
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

5.  Growth in and breakdown of purified rabbit small intestinal mucin by Yersinia enterocolitica.

Authors:  M Mantle; C Rombough
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

Review 6.  Sulphate reducing bacteria and hydrogen metabolism in the human large intestine.

Authors:  G R Gibson; G T Macfarlane; J H Cummings
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

7.  Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells.

Authors:  L de Repentigny; F Aumont; K Bernard; P Belhumeur
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Effects of tylosin on bacterial mucolysis, Clostridium perfringens colonization, and intestinal barrier function in a chick model of necrotic enteritis.

Authors:  C T Collier; J D van der Klis; B Deplancke; D B Anderson; H R Gaskins
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

9.  Utilization of mucin by oral Streptococcus species.

Authors:  J S van der Hoeven; C W van den Kieboom; P J Camp
Journal:  Antonie Van Leeuwenhoek       Date:  1990-04       Impact factor: 2.271

10.  Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins.

Authors:  L C Hoskins; M Agustines; W B McKee; E T Boulding; M Kriaris; G Niedermeyer
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.